FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39292611000001106: Irinotecan 270mg/180ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Jan 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
562551000001112 Irinotecan 270mg/180ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
562561000001110 Irinotecan 270mg/180ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Irinotecan 270mg/180ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Has dispensed dose form Infusion true Inferred relationship Existential restriction modifier
Irinotecan 270mg/180ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Irinotecan 270mg/180ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Is a Irinotecan 270mg/180ml infusion bags true Inferred relationship Existential restriction modifier
Irinotecan 270mg/180ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Irinotecan 270mg/180ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Irinotecan 270mg/180ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Has specific active ingredient Irinotecan hydrochloride trihydrate true Inferred relationship Existential restriction modifier
Irinotecan 270mg/180ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Irinotecan 270mg/180ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Irinotecan 270mg/180ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Has dispensed dose form Conventional release solution for infusion false Inferred relationship Existential restriction modifier
Irinotecan 270mg/180ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Irinotecan 270mg/180ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) 1 bag Has AMP True Irinotecan 270mg/180ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start